These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21245769)

  • 1. Your idea and your university: issues in academic technology transfer.
    Smith CD
    J Investig Med; 2011 Jun; 59(5):752-7. PubMed ID: 21245769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moving research to patient applications through commercialization: understanding and evaluating the role of intellectual property.
    Patino RM
    J Am Assoc Lab Anim Sci; 2010 Mar; 49(2):147-54. PubMed ID: 20353687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Navigating the Murky Waters of Conflict of Interest: Searching for the Middle Path.
    Zonia SC
    J Empir Res Hum Res Ethics; 2016 Feb; 11(1):67-71. PubMed ID: 27106892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patent and license pearls and pitfalls for taking an idea to the marketplace.
    Mukharji I
    J Investig Med; 2011 Jun; 59(5):758-61. PubMed ID: 21441827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administrative and research policies required to bring cellular therapies from the research laboratory to the patient's bedside.
    Yim R
    Transfusion; 2005 Oct; 45(4 Suppl):144S-58S. PubMed ID: 16181400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Science and business. Conflicts of interest--moving beyond disclosure.
    Cech TR; Leonard JS
    Science; 2001 Feb; 291(5506):989. PubMed ID: 11232584
    [No Abstract]   [Full Text] [Related]  

  • 8. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.
    Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB
    Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to Start a Biomedical Device Company: Physicians Can Lead the Team Effort.
    DiMaio JM; Potz BA; Thatcher JE; Squiers JJ
    JACC Basic Transl Sci; 2017 Jun; 2(3):328-334. PubMed ID: 30062152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Values in University-Industry Collaborations: The Case of Academics Working at Universities of Technology.
    Hillerbrand R; Werker C
    Sci Eng Ethics; 2019 Dec; 25(6):1633-1656. PubMed ID: 31620956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [RAMBAM - WHERE MEDICINE, TECHNOLOGY AND HUMANITY INTERTWINE].
    Beyar R
    Harefuah; 2017 Sep; 156(9):548-550. PubMed ID: 28971649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universities are forging ties with the FBI as US cracks down on foreign influence.
    Subbaraman N
    Nature; 2020 Mar; 579(7799):331. PubMed ID: 32184471
    [No Abstract]   [Full Text] [Related]  

  • 13. Policies on faculty conflicts of interest at US universities.
    Cho MK; Shohara R; Schissel A; Rennie D
    JAMA; 2000 Nov; 284(17):2203-8. PubMed ID: 11056591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regenerative Medicine Venturing at the University-Industry Boundary: Implications for Institutions, Entrepreneurs, and Industry.
    Bock AJ; Johnson D
    Adv Exp Med Biol; 2018; 1098():213-236. PubMed ID: 30238374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Commercialization of genetic research and its impact on the communication of results].
    Cardinal G
    Health Law J; 1999; 7():35-48, 33. PubMed ID: 11066367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion medicine technology transfer: traps to avoid.
    Mendes P
    Transfus Med Rev; 2002 Jan; 16(1):25-33. PubMed ID: 11788927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoting business and entrepreneurial awareness in health care professionals: lessons from venture capital panels at medicine 2.0 conferences.
    Miron-Shatz T; Shatz I; Becker S; Patel J; Eysenbach G
    J Med Internet Res; 2014 Aug; 16(8):e184. PubMed ID: 25100579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conflict-of-interest policies for investigators in clinical trials.
    Lo B; Wolf LE; Berkeley A
    N Engl J Med; 2000 Nov; 343(22):1616-20. PubMed ID: 11096170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. University-industry relationships in genetic research: potential opportunities and pitfalls.
    Walsh ME; Graber GC; Wolfe AK
    Account Res; 1997; 5(4):265-82. PubMed ID: 11656993
    [No Abstract]   [Full Text] [Related]  

  • 20. Resources for Starting a Company.
    Abraham A; Mathew J; Thomas S
    Methods Mol Biol; 2022; 2412():529-542. PubMed ID: 34918267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.